| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $977.7M | +17.6% |
| R&D Expense | $134.6M | +12.9% |
| SG&A Expense | $113.3M | +12.2% |
| Operating Income | $149.0M | +43.8% |
| Pre-tax Income | $139.5M | +5.2% |
| Income Tax | $18.3M | -53.3% |
| Net Income | $121.2M | +29.8% |
| EPS (Basic) | $0.34 | +30.8% |
| EPS (Diluted) | $0.31 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $497.5M | -19.4% |
| Accounts Receivable | $11.9M | +49.6% |
| Current Assets | $7.10B | -0.1% |
| Total Assets | $7.93B | +8.9% |
| Current Liabilities | $7.13B | +9.0% |
| Total Liabilities | $7.21B | +8.9% |
| Stockholders' Equity | $724.8M | +9.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $176.9M | +10.9% |
| Capital Expenditures | $8.2M | -3.2% |
| Investing Cash Flow | -$1.96B | -4331.8% |
| Financing Cash Flow | $427.8M | -16.4% |
| Free Cash Flow | $168.7M | +11.7% |
| +29.2% |